Structural Heart Program: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by drspine

Structural Heart Program Introduction (What it is)

A Structural Heart Program is a coordinated clinical service focused on diseases of the heart’s “structure,” especially heart valves, chambers, and nearby major vessels.
It brings multiple specialists together to evaluate symptoms, imaging, and treatment options in one pathway.
It is commonly used in hospitals and heart centers that perform advanced catheter-based and surgical heart procedures.
It often supports patients with valve disease, congenital (present-from-birth) heart conditions, or complications after prior heart surgery.

Why Structural Heart Program used (Purpose / benefits)

Structural heart disease refers to problems with the heart’s physical components—most often the valves (aortic, mitral, tricuspid, pulmonic), septum (the wall between chambers), and structures near the heart such as the aorta. These conditions can cause blood to flow the wrong direction (regurgitation), become obstructed (stenosis), or create abnormal openings or connections (such as atrial septal defects).

A Structural Heart Program exists to address several recurring challenges in this area of care:

Accurate diagnosis and severity grading. Many structural conditions require careful interpretation of echocardiography, CT, cardiac MRI, and cardiac catheterization data. Small differences in measurements can change treatment options.
Risk stratification and procedural planning. Patients are often older or have multiple medical conditions. Programs aim to match the condition and anatomy with an approach that fits the person’s overall risk profile.
Symptom evaluation and timing. Symptoms like shortness of breath, fatigue, fainting, chest discomfort, swelling, or reduced exercise tolerance can come from valve disease, coronary artery disease, lung disease, anemia, or other causes. A structured pathway helps clarify what is driving symptoms and whether intervention is likely to help.
Access to multiple treatment pathways. Structural care may involve monitoring, medication adjustments, catheter-based procedures (done through blood vessels), open or minimally invasive surgery, or hybrid approaches that combine techniques.
Team-based decision-making (“Heart Team”). Many programs use a multidisciplinary model so that interventional cardiology, cardiac surgery, imaging, anesthesia, and other specialists weigh options together, especially when more than one reasonable approach exists.
Longitudinal follow-up. Structural conditions often evolve over years, and implanted devices and repaired valves require ongoing surveillance. Programs typically standardize follow-up imaging and clinic visits.

In plain terms: a Structural Heart Program is designed to evaluate complex heart anatomy problems and coordinate the safest and most effective pathway for diagnosis, treatment, and follow-up—tailored to the individual’s anatomy, symptoms, and overall health.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Common scenarios where clinicians refer to or use a Structural Heart Program include:

Suspected or known aortic stenosis (narrowing of the aortic valve), especially when symptoms or echocardiogram findings suggest moderate-to-severe disease
Mitral regurgitation (leakage across the mitral valve), including degenerative (primary) and functional (secondary) causes
Tricuspid regurgitation, often in the setting of atrial enlargement, pulmonary hypertension, or prior left-sided valve disease
Evaluation for transcatheter valve therapies (catheter-based valve replacement or repair), when anatomy and overall risk need detailed assessment
Adult congenital heart disease issues that may involve holes between chambers (ASD/PFO), abnormal valve anatomy, or prior childhood repairs
Paravalvular leak (leak around a surgically implanted valve), which may cause heart failure symptoms or anemia from hemolysis
Left atrial appendage closure consideration in selected patients with atrial fibrillation who cannot take long-term blood thinners (eligibility varies by clinician and case)
Structural complications after heart attack or surgery (less common), such as ventricular septal defects or significant changes in valve function
Complex decisions when patients have overlapping problems, such as valve disease plus coronary artery disease, arrhythmias, or advanced heart failure

Contraindications / when it’s NOT ideal

A Structural Heart Program is a care model rather than a single procedure, so “contraindications” usually relate to whether the program pathway adds value or whether a different service is more appropriate. Situations where it may be less suitable or not the primary need include:

Symptoms unlikely to be structural in origin, such as shortness of breath primarily from lung disease or deconditioning (the overlap can be complex and requires clinician judgment)
Unstable emergencies that need immediate life-saving intervention (for example, certain acute heart attacks or shock states), where emergency or critical care pathways take precedence
Structural findings that are mild and clearly stable, where routine cardiology follow-up and periodic imaging may be sufficient
Severe comorbid illness where procedures are unlikely to offer meaningful benefit, such as advanced non-cardiac disease limiting life expectancy (decision-making varies by clinician and case)
Anatomy not suitable for a proposed catheter-based therapy, where surgical repair/replacement or conservative management may be more appropriate (varies by anatomy, device, and manufacturer)
Lack of access to experienced imaging, procedural volume, or surgical backup for certain advanced interventions, where referral to a higher-capability center may be considered
Patient preferences that do not align with invasive evaluation or intervention after informed discussion

How it works (Mechanism / physiology)

Because a Structural Heart Program is not one device or one test, its “mechanism” is primarily system-based: it organizes how structural heart diseases are detected, measured, and treated.

Key physiologic principles the program focuses on include:

Forward flow vs obstruction. Stenotic valves restrict forward blood flow, increasing pressure inside the heart chambers and limiting cardiac output (the amount of blood the heart pumps).
Backward leak (regurgitation). Leaky valves allow blood to flow backward, which can enlarge chambers (dilation), raise pressures in the lungs, and contribute to heart failure symptoms.
Pressure and volume effects on chambers. The left ventricle may thicken (hypertrophy) with pressure overload (e.g., aortic stenosis) or enlarge with volume overload (e.g., mitral regurgitation). The right side of the heart can be affected by lung pressures and tricuspid valve disease.
Interaction with rhythm and conduction. Atrial fibrillation can worsen valve-related symptoms by reducing coordinated filling, and some procedures can affect electrical conduction pathways, occasionally requiring pacing support (risk varies by procedure and patient factors).

Relevant anatomy commonly evaluated includes:

Valves: aortic, mitral, tricuspid, pulmonic
Chambers: left and right atria, left and right ventricles
Great vessels: aorta, pulmonary artery, venae cavae
Septum: atrial and ventricular septum
Coronary arteries: especially when planning combined coronary and valve treatment
Conduction system: atrioventricular node and bundle branches, especially in aortic valve interventions

Time course and interpretation:

Many structural conditions progress gradually, so serial imaging and symptom tracking matter.
Some interventions are durable but not permanent; valve prostheses and repairs can change over time, and longevity varies by material and manufacturer, as well as patient and procedural factors.
Program follow-up often focuses on whether symptoms improve, whether pressures and chamber sizes stabilize, and whether valve function remains acceptable on imaging.

Structural Heart Program Procedure overview (How it’s applied)

A Structural Heart Program typically applies a standardized workflow that coordinates evaluation, decision-making, intervention (if needed), and follow-up. Exact steps vary by center and case, but a common pathway includes:

Evaluation / exam
– History (symptoms, functional limits, prior procedures) and physical exam
– Baseline testing, often including ECG and labs as indicated
– Key imaging, usually transthoracic echocardiography; other imaging depends on the question
Advanced imaging and risk assessment
– Transesophageal echocardiography, cardiac CT, or cardiac MRI when more detail is needed
– Coronary assessment (noninvasive or invasive) when relevant
– Frailty, kidney function, lung disease, and other comorbidity assessment to estimate procedural risk (varies by clinician and case)
Multidisciplinary Heart Team review
– Structural/interventional cardiology, cardiac surgery, imaging specialists, anesthesia, and sometimes heart failure or electrophysiology
– Discussion of feasible options: monitoring, catheter-based therapy, surgery, or hybrid approaches
– Shared decision-making conversations with the patient and family, focusing on goals and tradeoffs
Preparation
– Procedural planning based on anatomy and access routes (for catheter-based therapies)
– Medication review (especially blood thinners), allergy history, and kidney-protection planning when contrast is used (plans vary)
Intervention / testing (when selected)
– Catheter-based procedures (through an artery or vein) or surgical procedures
– In selected cases, diagnostic catheterization to clarify pressures or valve severity
Immediate checks
– Post-procedure echocardiography or other imaging as indicated
– Monitoring for rhythm or conduction issues, vascular access complications, bleeding, kidney function changes, or stroke-like symptoms (risk varies)
Follow-up
– Clinic visits and repeat imaging at intervals based on the condition and intervention
– Coordination with primary cardiology and other specialties for long-term care

Types / variations

Structural Heart Program models differ across hospitals, but many include combinations of the following services and approaches:

Valve-focused clinics
Aortic stenosis evaluation pathways (often including consideration of transcatheter vs surgical replacement)
Mitral and tricuspid valve clinics emphasizing imaging-based mechanism assessment and staged treatment planning
Catheter-based (transcatheter) structural interventions
Transcatheter aortic valve replacement (TAVR) evaluation and follow-up
Transcatheter mitral repair (such as edge-to-edge repair) in selected anatomies (device choice varies by region, approval status, and case)
Transcatheter tricuspid repair or replacement options in selected centers (availability varies)
Closure procedures: ASD/PFO closure, paravalvular leak closure, select left atrial appendage closure cases
Surgical and minimally invasive structural surgery integration
Surgical valve repair or replacement
Minimally invasive valve surgery pathways where offered
Combined procedures (for example, valve plus coronary bypass) when appropriate
Imaging-centered structural programs
Specialized echocardiography, CT planning, and intra-procedural imaging expertise
Structural imaging conferences for complex measurements and device sizing
Adult congenital and complex structural disease pathways
Late complications of congenital defects or childhood repairs
Multispecialty coordination for anatomy that differs from typical adult patterns

Programs may also be described by focus area (valve program, transcatheter valve program, adult congenital program) or by care setting (inpatient consult service vs outpatient clinic with integrated testing).

Pros and cons

Pros:

Multidisciplinary review can clarify options when more than one approach is reasonable
Consolidates complex imaging and interpretation in one pathway
Supports individualized procedural planning based on anatomy and overall health
Often improves coordination between catheter-based and surgical teams
Standardized follow-up can help track valve function and symptoms over time
Useful for patients with prior heart surgery or complex anatomy

Cons:

Availability varies by hospital; some advanced therapies are not offered everywhere
Multiple appointments and tests may be needed before a decision is made
Not every patient is a candidate for catheter-based intervention; some still need surgery or monitoring
Insurance authorization and scheduling logistics can add delays (varies by system)
Complex discussions can feel overwhelming without clear education and support
Outcomes depend on many factors, including anatomy, comorbidities, and procedural experience (varies by clinician and case)

Aftercare & longevity

Aftercare in a Structural Heart Program depends on the underlying condition (for example, valve stenosis vs regurgitation) and the treatment approach (monitoring, catheter-based intervention, or surgery). In general, programs emphasize:

Ongoing surveillance. Repeat echocardiography is commonly used to track valve gradients, leak severity, chamber size, and heart function. The schedule varies by condition and intervention.
Symptom and functional assessment. Many clinics reassess exercise tolerance, breathing, swelling, and quality-of-life measures over time, because imaging findings and symptoms do not always match perfectly.
Medication coordination. Patients with valve disease often take medicines for blood pressure, fluid management, rhythm control, cholesterol, or anticoagulation when indicated. The exact regimen is individualized by the treating team.
Rhythm and conduction monitoring. Some patients need ECG follow-up, ambulatory monitoring, or device checks after structural procedures, depending on the clinical scenario.
Rehabilitation and risk-factor management. Cardiac rehabilitation or structured exercise programs may be used after major interventions when appropriate and available. Control of blood pressure, diabetes, sleep apnea, and smoking status can influence long-term heart function.
Durability considerations. Surgical and transcatheter valve prostheses and repairs have variable longevity. Durability can be influenced by patient age, valve position, calcium burden, infection risk, and device/material characteristics (varies by material and manufacturer).

Alternatives / comparisons

A Structural Heart Program is not the only way to manage structural disease, but it is a common model for coordinating complex decisions. High-level comparisons include:

Observation/monitoring vs intervention
Mild or stable valve disease may be managed with periodic imaging and symptom monitoring.
Moderate-to-severe disease with symptoms or organ effects may prompt consideration of an intervention, but timing is individualized.
Medication management vs structural repair/replacement
Medicines can reduce symptoms (for example, by controlling blood pressure or fluid overload) and treat contributing conditions.
Medicines generally do not “fix” a severely narrowed or severely leaking valve; mechanical problems often require repair or replacement when appropriate.
Noninvasive testing vs invasive testing
Echocardiography, CT, and MRI provide extensive structural information without catheter entry into the heart.
Cardiac catheterization may be used when pressure measurements, coronary assessment, or clarification of severity is needed; it is invasive and carries different risks.
Catheter-based vs surgical approaches
Catheter-based procedures can reduce recovery time for some patients and may be favored in selected risk profiles and anatomies.
Surgery can be more suitable for certain anatomies, multi-valve disease, need for concurrent bypass, or when repair durability is a priority. Suitability varies by clinician and case.
General cardiology care vs program-based care
Many patients can be managed well by a general cardiologist with periodic imaging.
A program is often used when the case is complex, when advanced transcatheter options are being considered, or when multidisciplinary input is helpful.

Structural Heart Program Common questions (FAQ)

Q: Is a Structural Heart Program only for people who need surgery?
No. Many referrals are for evaluation and monitoring, not immediate intervention. The program helps determine whether symptoms are due to a structural problem and whether treatment should be medical, catheter-based, surgical, or simply continued surveillance.

Q: What conditions are most commonly evaluated?
Valve diseases—especially aortic stenosis and mitral regurgitation—are frequent reasons for referral. Programs also commonly assess tricuspid valve disease, congenital defects like ASD/PFO, and complications such as leaks around prior valve replacements.

Q: Will the evaluation be painful?
Most of the evaluation involves office visits and noninvasive imaging like transthoracic echocardiography, which is typically not painful. Some tests, such as transesophageal echocardiography or cardiac catheterization, can be more invasive and may involve sedation; the experience varies by test and patient.

Q: How long do results or benefits last after a structural heart procedure?
Durability depends on the condition, the specific procedure, the valve position, and the device or repair method used. Some repairs and replacements can function well for many years, but no approach is guaranteed to last indefinitely, and follow-up imaging is used to monitor changes over time.

Q: How safe are structural heart procedures?
Safety varies by the procedure, the patient’s overall health, and the experience of the treating team. Programs typically focus on careful selection, detailed imaging, and standardized monitoring to reduce risk, but complications can still occur.

Q: Will I need to stay in the hospital?
Some catheter-based procedures may involve short hospitalization, while others require longer stays, especially with open surgery. Length of stay depends on the procedure type, recovery progress, and any complications (varies by clinician and case).

Q: What is recovery like after a catheter-based vs surgical approach?
Catheter-based procedures often have a shorter initial recovery than open surgery, but recovery still depends on age, strength, heart function, and other medical conditions. Surgical recovery may be longer, especially after sternotomy, but it can be the preferred option for certain anatomies or combined surgical needs.

Q: Are there activity restrictions afterward?
Restrictions depend on the intervention and access site (for catheter procedures) or the incision and healing needs (for surgery). Programs typically provide individualized guidance based on the procedure performed and the patient’s overall status.

Q: What does a Structural Heart “Heart Team” mean for patients?
It means multiple specialists review the case together—often including interventional cardiology, cardiac surgery, and cardiac imaging. This approach is used to compare feasible options and align recommendations with anatomy, risks, and patient goals.

Q: How much does Structural Heart Program care cost?
Costs vary widely based on testing, procedures, hospitalization, insurance coverage, and regional factors. Many centers have financial counseling teams who can explain expected charges and coverage pathways in general terms.